Pea protein drink may help Crohn's patients during Flare-Ups
NCT ID NCT07113431
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a dietary plan combining a special diet for inflammatory bowel disease (IBD-AID) with a pea protein drink (Kate Farms Peptide 1.5) in 20 adults experiencing a Crohn's disease flare and starting new immunologic therapy. The goal was to see if this approach improves nutrient intake and body composition compared to the diet alone. The study measured dietary recall and body composition using bioimpedance spectroscopy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pea protein plant-based oral nutrition supplement (Kate Farms Peptide 1.5) combined with a standardized IBD diet
What this could lead to
If successful, this dietary approach could help improve nutrition and body composition during Crohn's flares, potentially supporting better outcomes with new immunologic therapy.
What could go wrong
This is a small, completed trial with only 20 participants, so results may not apply broadly. The intervention is dietary and may not significantly alter disease course.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE(CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States